atropine has been researched along with ranolazine in 2 studies
| Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (ranolazine) | Trials (ranolazine) | Recent Studies (post-2010) (ranolazine) |
|---|---|---|---|---|---|
| 26,711 | 1,259 | 1,697 | 799 | 104 | 498 |
| Protein | Taxonomy | atropine (IC50) | ranolazine (IC50) |
|---|---|---|---|
| Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | 6.85 | |
| Voltage-gated sodium channel Nav1.5 cardiac isoform | Canis lupus familiaris (dog) | 6.9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Antzelevitch, C; Belardinelli, L; Blazek, J; Sicouri, S | 1 |
1 review(s) available for atropine and ranolazine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for atropine and ranolazine
| Article | Year |
|---|---|
Electrophysiological characteristics of canine superior vena cava sleeve preparations: effect of ranolazine.
Topics: Acetanilides; Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atropine; Dogs; Electrophysiological Phenomena; Enzyme Inhibitors; Models, Animal; Ouabain; Piperazines; Pulmonary Veins; Ranolazine; Vena Cava, Superior | 2012 |